07.16.15
Salt Lake City, Utah-based Great Basin Scientific Inc. has added Carlos B. González, Ph.D. to its management team as vice president of engineering. González brings more than 20 years of medical device engineering and research experience—including tenure at market leaders such as Abbott and Siemens—to the molecular diagnostics company,
As vice president of engineering, González will be responsible for leading the development of the next major platform upgrade to Great Basin’s analyzer, which the company envisions will offer higher testing throughput in a significantly smaller footprint with a much shortened time to result. These enhancements will more efficiently accommodate the company’s growing menu of low-plex and multiplex diagnostic tests and improve workflow as well as offer expanded reporting at customer sites. Great Basin expects to deliver the enhanced analyzer in 2016.
“With significant progress made on our test menu and our successful execution against our business plan, Great Basin is now poised to tackle enhancements to our instrumentation that will add significant value for our customers,” said Great Basin co-founder and CEO Ryan Ashton. “Our upgraded platform will be designed to shrink the instrument size and deliver faster time-to-result while using the same test cartridges as our current instrument. Additionally, we plan to enhance our usability and workflow benefits with an outstanding Apple-like user interface and flexible, powerful back-end reporting functionality that connects to the hospital or lab information system. We’re excited to have Carlos on board to develop this and future system enhancements that can be seamlessly adopted by our customers and will continue to simplify diagnostic workflow.”
Prior to Great Basin, González served as research and development director of instrument development at Abbott Point of Care. Previous to his position with Abbott POC, he held positions in new technology development with Siemens Diagnostics, Abbott Pharmaceutical (now Abbvie), and Lawrence Livermore National Laboratories. González received his Ph.D. in electrical engineering from the University of California at Davis.
“I watched Great Basin quickly set itself apart from others in the molecular diagnostics space in the way they address workflow and cost, two issues that have previously limited the adoption of molecular diagnostics,” said González. “I am thrilled to join the Great Basin team as I share their vision for revolutionizing the way labs test and report results to clinicians. I look forward to applying my diagnostics-systems experience to the technology foundation that Great Basin has already established to deliver even greater value for our customers.”
As vice president of engineering, González will be responsible for leading the development of the next major platform upgrade to Great Basin’s analyzer, which the company envisions will offer higher testing throughput in a significantly smaller footprint with a much shortened time to result. These enhancements will more efficiently accommodate the company’s growing menu of low-plex and multiplex diagnostic tests and improve workflow as well as offer expanded reporting at customer sites. Great Basin expects to deliver the enhanced analyzer in 2016.
“With significant progress made on our test menu and our successful execution against our business plan, Great Basin is now poised to tackle enhancements to our instrumentation that will add significant value for our customers,” said Great Basin co-founder and CEO Ryan Ashton. “Our upgraded platform will be designed to shrink the instrument size and deliver faster time-to-result while using the same test cartridges as our current instrument. Additionally, we plan to enhance our usability and workflow benefits with an outstanding Apple-like user interface and flexible, powerful back-end reporting functionality that connects to the hospital or lab information system. We’re excited to have Carlos on board to develop this and future system enhancements that can be seamlessly adopted by our customers and will continue to simplify diagnostic workflow.”
Prior to Great Basin, González served as research and development director of instrument development at Abbott Point of Care. Previous to his position with Abbott POC, he held positions in new technology development with Siemens Diagnostics, Abbott Pharmaceutical (now Abbvie), and Lawrence Livermore National Laboratories. González received his Ph.D. in electrical engineering from the University of California at Davis.
“I watched Great Basin quickly set itself apart from others in the molecular diagnostics space in the way they address workflow and cost, two issues that have previously limited the adoption of molecular diagnostics,” said González. “I am thrilled to join the Great Basin team as I share their vision for revolutionizing the way labs test and report results to clinicians. I look forward to applying my diagnostics-systems experience to the technology foundation that Great Basin has already established to deliver even greater value for our customers.”